Chromogranin a Is a Predictor of Prognosis in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s190678
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Tissue Biomarkers for Prognosis of Prostate Cancer: A Systematic Review and Meta-Analysis

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2014English

CD147 and Prostate Cancer: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2016English

Correction: Reduced E-Cadherin Expression Is Correlated With Poor Prognosis in Patients With Bladder Cancer: A Systematic Review and Meta-Analysis

Oncotarget
Oncology
2019English

Aspirin Exposure and Mortality Risk Among Prostate Cancer Patients: A Systematic Review and Meta-Analysis

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

First-Degree Family History of Breast Cancer Is Associated With Prostate Cancer Risk: A Systematic Review and Meta-Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Evaluation of Prostate Cancer Antigen 3 for Detecting Prostate Cancer: A Systematic Review and Meta-Analysis

Scientific Reports
Multidisciplinary
2016English

Could Aspirin Be a Lifesaver for Prostate Cancer Patients in Prostate Cancer-Specific Mortality?: An Update Systematic Review and Meta-Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Diabetes and Mortality in Patients With Prostate Cancer: A Meta-Analysis

SpringerPlus
Multidisciplinary
2016English

CD44 Expression Is Predictive of Poor Prognosis in Pharyngolaryngeal Cancer: Systematic Review and Meta-Analysis

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy